Madrigal Pharmaceuticals Inc (MDGL)

82.55 +0.75  +0.92% NASDAQ Nov 30, 16:00 82.55 0.00  0.00% After-Hours: 20:00 USD

Madrigal Pharmaceuticals SG&A Expense (Quarterly):

8.287M for Sept. 30, 2021
View 4,000+ financial data types
Browse...
View Full Chart

SG&A Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Historical SG&A Expense (Quarterly) Data

View and export this data going back to 2005. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 8.287M
June 30, 2021 10.11M
March 31, 2021 7.209M
Dec. 31, 2020 6.126M
Sept. 30, 2020 5.494M
June 30, 2020 5.639M
March 31, 2020 4.605M
Dec. 31, 2019 5.044M
Sept. 30, 2019 4.748M
June 30, 2019 7.11M
March 31, 2019 5.746M
Dec. 31, 2018 5.583M
Sept. 30, 2018 5.122M
June 30, 2018 2.717M
March 31, 2018 1.871M
Dec. 31, 2017 2.399M
Sept. 30, 2017 1.955M
June 30, 2017 1.623M
March 31, 2017 1.695M
Dec. 31, 2016 2.232M
Sept. 30, 2016 6.285M
June 30, 2016 0.551M
March 31, 2016 0.222M
Dec. 31, 2015 0.1451M
Sept. 30, 2015 0.1974M
   
June 30, 2015 3.127M
March 31, 2015 4.15M
Dec. 31, 2014 4.241M
Sept. 30, 2014 3.241M
June 30, 2014 2.94M
March 31, 2014 5.324M
Dec. 31, 2013 3.463M
Sept. 30, 2013 4.171M
June 30, 2013 4.187M
March 31, 2013 3.878M
Dec. 31, 2012 3.352M
Sept. 30, 2012 2.796M
June 30, 2012 2.882M
March 31, 2012 2.646M
Dec. 31, 2011 2.803M
Sept. 30, 2011 3.131M
June 30, 2011 2.946M
March 31, 2011 2.673M
Dec. 31, 2010 3.056M
Sept. 30, 2010 2.591M
June 30, 2010 2.716M
March 31, 2010 3.086M
Dec. 31, 2009 2.427M
Sept. 30, 2009 3.149M
June 30, 2009 3.005M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Benchmarks

908 Devices Inc 8.786M
NovaBay Pharmaceuticals Inc 3.626M
Palatin Technologies Inc 3.836M

SG&A Expense (Quarterly) Range, Past 5 Years

Minimum 1.623M Jun 2017
Maximum 10.11M Jun 2021
Average 4.766M

News

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.